The effect of prolyl oligopeptidase inhibition on extracellular acetylcholine and dopamine levels in the rat striatum

Neurochemistry International

Volumn 60, Issue 3, 2012, Pages 301-309

  Jalkanen, Aaro J ^a   Piepponen, T Petteri ^b   Hakkarainen, Jenni J ^a   De Meester, Ingrid ^c   Lambeir, Anne Marie ^c   Forsberg, Markus M ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Acetylcholine; Dopamine; Microdialysis; Prolyl oligopeptidase; Rat

Indexed keywords

ACETYLCHOLINE; DOPAMINE; KYP 2047; N BENZYL 2 [[2 (HYDROXYACETYL) 1 PYRROLIDINYL]CARBONYL] 1 PYRROLIDINECARBOXAMIDE; PROLYL ENDOPEPTIDASE; PROLYL ENDOPEPTIDASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BLOOD LEVEL; ENZYME INHIBITION; EXTRACELLULAR MATRIX; IN VITRO STUDY; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

3,4-DIHYDROXYPHENYLACETIC ACID; ACETYLCHOLINE; ANIMALS; CORPUS STRIATUM; DOPAMINE; HOMOVANILLIC ACID; MALE; MICRODIALYSIS; PROLINE; PYRROLIDINES; RATS; RATS, WISTAR; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS;

RATTUS; RODENTIA;

EID: 84856348101     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.12.010     Document Type: Article

References (79)

1. E.D. Abercrombie, and P. DeBoer Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism J. Neurosci. 17 1997 8498 8505 (Pubitemid 27461071)
2. N. Agirregoitia, R. Laiz-Carrion, A. Varona, M.P. Rio, J.M. Mancera, and J. Irazusta Distribution of peptidase activity in teleost and rat tissues J. Comp. Physiol. B 175 2005 433 444 (Pubitemid 41242162)
3. G. Bellemere, P. Morain, H. Vaudry, and S. Jegou Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and alpha-melanocyte- stimulating hormone breakdown in the rat brain J. Neurochem. 84 2003 919 929 (Pubitemid 36330646)
4. G. Bellemere, H. Vaudry, P. Morain, and S. Jegou Effect of prolyl endopeptidase inhibition on arginine-vasopressin and thyrotrophin-releasing hormone catabolism in the rat brain J. Neuroendocrinol. 17 2005 306 313 (Pubitemid 40711626)
5. H. Benveniste, and P.C. Huttemeier Microdialysis - Theory and application Prog. Neurobiol. 35 1990 195 215 (Pubitemid 20270228)
6. A.E. Brady, C.K. Jones, T.M. Bridges, J.P. Kennedy, A.D. Thompson, J.U. Heiman, M.L. Breininger, P.R. Gentry, H. Yin, S.B. Jadhav, J.K. Shirey, P.J. Conn, and C.W. Lindsley Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats J. Pharmacol. Exp. Ther. 327 2008 941 953
7. I. Brandt, K. De Vriendt, B. Devreese, J. Van Beeumen, W. Van Dongen, K. Augustyns, I. De Meester, S. Scharpe, and A.M. Lambeir Search for substrates for prolyl oligopeptidase in porcine brain Peptides 26 2005 2536 2546 (Pubitemid 41676729)
8. I. Brandt, M. Gerard, K. Sergeant, B. Devreese, V. Baekelandt, K. Augustyns, S. Scharpe, Y. Engelborghs, and A.M. Lambeir Prolyl oligopeptidase stimulates the aggregation of alpha-synuclein Peptides 29 2008 1472 1478
9. P. Calabresi, D. Centonze, P. Gubellini, and G. Bernardi Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP Neuropharmacology 38 1999 323 326 (Pubitemid 29073555)
10. T.R. Castaneda, B.M. de Prado, D. Prieto, and F. Mora Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light J. Pineal Res. 36 2004 177 185 (Pubitemid 38429283)
11. M.A. Cavasin, N.E. Rhaleb, X.P. Yang, and O.A. Carretero Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP Hypertension 43 2004 1140 1145 (Pubitemid 38579927)
12. Q. Chang, and P.E. Gold Switching memory systems during learning: changes in patterns of brain acetylcholine release in the hippocampus and striatum in rats J. Neurosci. 23 2003 3001 3005 (Pubitemid 36418636)
13. Q. Chang, L.M. Savage, and P.E. Gold Microdialysis measures of functional increases in ACh release in the hippocampus with and without inclusion of acetylcholinesterase inhibitors in the perfusate J. Neurochem. 97 2006 697 706
14. C.S. Chaurasia, M. Muller, E.D. Bashaw, E. Benfeldt, J. Bolinder, R. Bullock, P.M. Bungay, E.C. DeLange, H. Derendorf, W.F. Elmquist, M. Hammarlund-Udenaes, C. Joukhadar, D.L. Kellogg Jr., C.E. Lunte, C.H. Nordstrom, H. Rollema, R.J. Sawchuk, B.W. Cheung, V.P. Shah, L. Stahle, U. Ungerstedt, D.F. Welty, and H. Yeo AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives Pharm. Res. 24 2007 1014 1025 (Pubitemid 46675390)
15. D.F. Cunningham, and B. O'Connor Proline specific peptidases Biochim. Biophys. Acta 1343 1997 160 186 (Pubitemid 28015033)
16. S. Deiana, B. Platt, and G. Riedel The cholinergic system and spatial learning Behav. Brain Res. 221 2011 389 411
17. E. Di Daniel, C.P. Glover, E. Grot, M.K. Chan, T.H. Sanderson, J.H. White, C.L. Ellis, K.T. Gallagher, J. Uney, J. Thomas, P.R. Maycox, and A.W. Mudge Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity Mol. Cell. Neurosci. 41 2009 373 382
18. V. Dubois, A.M. Lambeir, S. Vandamme, V. Matheeussen, Y. Guisez, S. Scharpé, and I. De Meester Dipeptidyl peptidase 9 (DPP9) from bovine testes Biochim. Biophys. Acta. 1804 2010 781 788
19. M. Fuxreiter, C. Magyar, T. Juhasz, Z. Szeltner, L. Polgar, and I. Simon Flexibility of prolyl oligopeptidase: molecular dynamics and molecular framework analysis of the potential substrate pathways Proteins 60 2005 504 512 (Pubitemid 41061642)
20. A. Gaggar, P.L. Jackson, B.D. Noerager, P.J. O'Reilly, D.B. McQuaid, S.M. Rowe, J.P. Clancy, and J.E. Blalock A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation J. Immunol. 180 2008 5662 5669
21. S. Graef, P. Schonknecht, O. Sabri, and U. Hegerl Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings Psychopharmacology (Berlin) 215 2011 205 229
22. R. Havekes, T. Abel, and E.A. Van der Zee The cholinergic system and neostriatal memory functions Behav. Brain Res. 221 2011 412 423
23. A.M. Himmelheber, J. Fadel, M. Sarter, and J.P. Bruno Effects of local cholinesterase inhibition on acetylcholine release assessed simultaneously in prefrontal and frontoparietal cortex Neuroscience 86 1998 949 957 (Pubitemid 28298749)
24. J.P. Huston, and R.U. Hasenohrl The role of neuropeptides in learning: focus on the neurokinin substance P Behav. Brain Res. 66 1995 117 127
25. J. Irazusta, G. Larrinaga, J. Gonzalez-Maeso, J. Gil, J.J. Meana, and L. Casis Distribution of prolyl endopeptidase activities in rat and human brain Neurochem. Int. 40 2002 337 345 (Pubitemid 34131608)
26. A.J. Jalkanen, J.J. Hakkarainen, M. Lehtonen, T. Venäläinen, T.M. Kääriäinen, E.M. Jarho, M. Suhonen, and M.M. Forsberg Brain pharmacokinetics of two prolyl oligopetidase inhibitors, JTP-4819 and KYP-2047, in the rat Basic Clin. Pharmacol. Toxicol. 109 2011 443 451
27. A.J. Jalkanen, K.A. Puttonen, J.I. Venäläinen, V. Sinervä, A. Mannila, S. Ruotsalainen, E.M. Jarho, E.A. Wallen, and P.T. Männistö Beneficial effect of prolyl oligopeptidase inhibition on spatial memory in young but not in old scopolamine-treated rats Basic Clin. Pharmacol. Toxicol. 100 2007 132 138 (Pubitemid 46146718)
28. A.J. Jalkanen, K. Savolainen, and M.M. Forsberg Inhibition of prolyl oligopeptidase by KYP-2047 fails to increase the extracellular neurotensin and substance P levels in rat striatum Neurosci. Lett. 502 2011 107 111
29. E.M. Jarho, J.I. Venäläinen, J. Huuskonen, J.A. Christiaans, J.A. Garcia-Horsman, M.M. Forsberg, T. Järvinen, J. Gynther, P.T. Männistö, and E.A. Wallen A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors J. Med. Chem. 47 2004 5605 5607 (Pubitemid 39447255)
30. J. Jeon, D. Dencker, G. Wortwein, D.P. Woldbye, Y. Cui, A.A. Davis, A.I. Levey, G. Schutz, T.N. Sager, A. Mork, C. Li, C.X. Deng, A. Fink-Jensen, and J. Wess A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors J. Neurosci. 30 2010 2396 2405
31. J. Joossens, P. Van der Veken, G. Surpateanu, A.M. Lambeir, I. El-Sayed, O.M. Ali, K. Augustyns, and A. Haemers Diphenyl phosphonate inhibitors for the urokinase-type plasminogen activator: optimization of the P4 position J. Med. Chem. 49 2006 5785 5793 (Pubitemid 44423715)
32. J. Kehr, X.J. Hu, T. Yoshitake, F.H. Wang, P. Osborne, C. Stenfors, and S.O. Ogren The selective 5-HT(1A) receptor antagonist NAD-299 increases acetylcholine release but not extracellular glutamate levels in the frontal cortex and hippocampus of awake rat Eur. Neuropsychopharmacol. 20 2010 487 500
33. P. Keski-Rahkonen, M. Lehtonen, J. Ihalainen, T. Sarajärvi, and S. Auriola Quantitative determination of acetylcholine in microdialysis samples using liquid chromatography/atmospheric pressure spray ionization mass spectrometry Rapid Commun. Mass Spectrom. 21 2007 2933 2943 (Pubitemid 47401429)
34. G.L. Kovacs, and D. De Wied Peptidergic modulation of learning and memory processes Pharmacol. Rev. 46 1994 269 291 (Pubitemid 24310131)
35. J. Lehmann, and S.Z. Langer The striatal cholinergic interneuron: synaptic target of dopaminergic terminals? Neuroscience 10 1983 1105 1120 (Pubitemid 14178563)
36. E. Messamore, N. Ogane, and E. Giacobini Cholinesterase inhibitor effects on extracellular acetylcholine in rat striatum Neuropharmacology 32 1993 291 296 (Pubitemid 23085276)
37. J. Micheau, and A. Marighetto Acetylcholine and memory: a long, complex and chaotic but still living relationship Behav. Brain Res. 221 2011 424 429
38. M.J. Millan, B. Di Cara, M. Hill, M. Jackson, J.N. Joyce, J. Brotchie, S. McGuire, A. Crossman, L. Smith, P. Jenner, A. Gobert, J.L. Peglion, and M. Brocco S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole J. Pharmacol. Exp. Ther. 309 2004 921 935 (Pubitemid 38669678)
39. P. Morain, P. Lestage, G. De Nanteuil, R. Jochemsen, J.L. Robin, D. Guez, and P.A. Boyer S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies CNS Drug Rev. 8 2002 31 52 (Pubitemid 34651314)
40. T. Myhrer Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks Brain Res. Brain Res. Rev. 41 2003 268 287 (Pubitemid 36355883)
41. T.T. Myöhänen, J. Tenorio-Laranga, B. Jokinen, R. Vázquez-Sánchez, M.J. Moreno-Baylach, J.A. García-Horsman, and P.T. Männistö Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner Br. J. Pharmacol. 163 2011 1666 1678
42. T.T. Myöhänen, J.I. Venäläinen, J.A. Garcia-Horsman, M. Piltonen, and P.T. Männistö Cellular and subcellular distribution of rat brain prolyl oligopeptidase and its association with specific neuronal neurotransmitters J. Comp. Neurol. 507 2008 1694 1708 (Pubitemid 351468218)
43. T.T. Myöhänen, J.I. Venäläinen, E. Tupala, J.A. Garcia-Horsman, R. Miettinen, and P.T. Männistö Distribution of immunoreactive prolyl oligopeptidase in human and rat brain Neurochem. Res. 32 2007 1365 1374 (Pubitemid 46988198)
44. P.T. Männistö, J. Venäläinen, A. Jalkanen, and J.A. Garcia-Horsman Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders Drug News. Perspect. 20 2007 293 305 (Pubitemid 47345221)
45. W.M. Nolte, D.M. Tagore, W.S. Lane, and A. Saghatelian Peptidomics of prolyl endopeptidase in the central nervous system Biochemistry 48 2009 11971 11981
46. G. Paxinos, and C.D. Watson The Rat Brain in Stereotaxic Coordinates sixth ed. 2007 Elsevier London
47. I. Peltonen, T.T. Myöhänen, and P.T. Männistö Association of prolyl oligopeptidase with conventional neurotransmitters in the brain CNS Neurol. Disord. Drug Targets 10 2011 311 318
48. S. Perez, A. Tierney, J.M. Deniau, and M.L. Kemel Tachykinin regulation of cholinergic transmission in the limbic/prefrontal territory of the rat dorsal striatum: implication of new neurokinine 1-sensitive receptor binding site and interaction with enkephalin/mu opioid receptor transmission J. Neurochem. 103 2007 2153 2163 (Pubitemid 350173578)
49. J.C. Pych, Q. Chang, C. Colon-Rivera, and P.E. Gold Acetylcholine release in hippocampus and striatum during testing on a rewarded spontaneous alternation task Neurobiol. Learn. Mem. 84 2005 93 101 (Pubitemid 41140409)
50. J.C. Pych, Q. Chang, C. Colon-Rivera, R. Haag, and P.E. Gold Acetylcholine release in the hippocampus and striatum during place and response training Learn. Mem. 12 2005 564 572 (Pubitemid 41770079)
51. I. Schulz, B. Gerhartz, A. Neubauer, A. Holloschi, U. Heiser, M. Hafner, and H.U. Demuth Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition Eur. J. Biochem. 269 2002 5813 5820 (Pubitemid 35425579)
52. I. Schulz, U. Zeitschel, T. Rudolph, D. Ruiz-Carrillo, J.U. Rahfeld, B. Gerhartz, V. Bigl, H.U. Demuth, and S. Rossner Subcellular localization suggests novel functions for prolyl endopeptidase in protein secretion J. Neurochem. 94 2005 970 979 (Pubitemid 41170585)
53. K. Senten, P. Van der Veken, I. De Meester, A.M. Lambeir, S. Scharpe, A. Haemers, and K. Augustyns Design, synthesis, and SAR of potent and selective dipeptide-derived inhibitors for dipeptidyl peptidases J. Med. Chem. 46 2003 5005 5014 (Pubitemid 37352037)
54. M. Shinoda, A. Matsuo, and K. Toide Pharmacological studies of a novel prolyl endopeptidase inhibitor, JTP-4819, in rats with middle cerebral artery occlusion Eur. J. Pharmacol. 305 1996 31 38 (Pubitemid 26196814)
55. M. Shinoda, A. Miyazaki, and K. Toide Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and on cholinergic and peptidergic neurons in rats with ibotenate-induced lesions of the nucleus basalis magnocellularis Behav. Brain Res. 99 1999 17 25 (Pubitemid 29084523)
56. I. Smolders, L. Bogaert, G. Ebinger, and Y. Michotte Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis J. Neurochem. 68 1997 1942 1948 (Pubitemid 27176130)
57. F. St-Gelais, C. Jomphe, and L.E. Trudeau The role of neurotensin in central nervous system pathophysiology: what is the evidence? J. Psychiatry Neurosci. 31 2006 229 245 (Pubitemid 44085829)
58. A. Stöckel-Maschek, B. Stiebitz, R. Koelsch, and K. Neubert A continuous fluorimetric assay for aminopeptidase P detailed analysis of product inhibition Anal. Biochem. 322 2003 60 67 (Pubitemid 37188557)
59. Z. Szeltner, M. Morawski, T. Juhasz, I. Szamosi, K. Liliom, V. Csizmok, F. Tolgyesi, and L. Polgar GAP43 shows partial co-localisation but no strong physical interaction with prolyl oligopeptidase Biochim. Biophys. Acta 1804 2010 2162 2176
60. J. Tenorio-Laranga, F. Coret-Ferrer, B. Casanova-Estruch, M. Burgal, and J.A. García-Horsman Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis J. Neuroinflamm. 7 2010 23
61. J. Tenorio-Laranga, M.L. Valero, P.T. Männistö, M. Sanchez del Pino, and J.A. García-Horsman Combination of snap freezing, differential pH two-dimensional reverse-phase high-performance liquid chromatography, and iTRAQ technology for the peptidomic analysis of the effect of prolyl oligopeptidase inhibition in the rat brain Anal. Biochem. 393 2009 80 87
62. S. Threlfell, M.A. Clements, T. Khodai, I.S. Pienaar, R. Exley, J. Wess, and S.J. Cragg Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum J. Neurosci. 30 2010 3398 3408
63. K. Toide, T. Fujiwara, Y. Iwamoto, M. Shinoda, K. Okamiya, and T. Kato Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 353 1996 355 362 (Pubitemid 26092052)
64. K. Toide, Y. Iwamoto, T. Fujiwara, and H. Abe JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer J. Pharmacol. Exp. Ther. 274 1995 1370 1378
65. K. Toide, K. Okamiya, Y. Iwamoto, and T. Kato Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on prolyl endopeptidase activity and substance P- and arginine-vasopressin-like immunoreactivity in the brains of aged rats J. Neurochem. 65 1995 234 240
66. K. Toide, M. Shinoda, T. Fujiwara, and Y. Iwamoto Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats Pharmacol. Biochem. Behav. 56 1997 427 434 (Pubitemid 27145822)
67. K. Toide, M. Shinoda, M. Takase, K. Iwata, and H. Yoshida Effects of a novel thyrotropin-releasing hormone analogue, JTP-2942, on extracellular acetylcholine and choline levels in the rat frontal cortex and hippocampus Eur. J. Pharmacol. 233 1993 21 28 (Pubitemid 23091739)
68. H. Toy, H. Camuzcuoglu, D.T. Arioz, S. Kurt, H. Celik, and N. Aksoy Serum prolidase activity and oxidative stress markers in pregnancies with intrauterine growth restricted infants J. Obstet. Gynaecol. Res. 35 2009 1047 1053
69. A. Turzynski, and R. Mentlein Prolyl aminopeptidase from rat brain and kidney. Action on peptides and identification as leucyl aminopeptidase Eur. J. Biochem. 190 1990 509 515
70. K. Umemura, K. Kondo, Y. Ikeda, T. Kobayashi, Y. Urata, and M. Nakashima Pharmacokinetics and safety of JTP-4819, a novel specific orally active prolyl endopeptidase inhibitor, in healthy male volunteers Br. J. Clin. Pharmacol. 43 1997 613 618 (Pubitemid 27283570)
71. H. Umetsu, M. Abe, Y. Sugawara, T. Nakai, S. Watanabe, and E. Ichishima Purification, crystallisation and characterisation of carboxypeptidase from wheat bran Food Chem. 7 1981 125 138
72. M. Uramatsu, G. Liu, S. Uramatsu, M. Zhang, W. Wang, K. Nakayama, M. Manabe, and H. Kodama Different effects of sulfur amino acids on prolidase and prolinase activity in normal and prolidase-deficient human erythrocytes Clin. Chim. Acta 375 2007 129 135 (Pubitemid 44584233)
73. S. Van Goethem, V. Matheeussen, J. Joossens, A.M. Lambeir, X. Chen, I. De Meester, A. Haemers, K. Augustyns, and P. Van der Veken Structure-activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 9 (DPP8, DPP9): is DPP8-selectivity an attainable goal? J. Med. Chem. 54 2011 5737 5746
74. J.I. Venäläinen, J.A. Garcia-Horsman, M.M. Forsberg, A. Jalkanen, E.A. Wallén, E.M. Jarho, J.A. Christiaans, J. Gynther, and P.T. Männistö Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors Biochem. Pharmacol. 71 2006 683 692 (Pubitemid 43122001)
75. J.I. Venäläinen, R.O. Juvonen, M.M. Forsberg, A. Garcia-Horsman, A. Poso, E.A. Wallén, J. Gynther, and P.T. Männistö Substrate-dependent, non-hyperbolic kinetics of pig brain prolyl oligopeptidase and its tight binding inhibition by JTP-4819 Biochem. Pharmacol. 64 2002 463 471 (Pubitemid 34874849)
76. J.I. Venäläinen, R.O. Juvonen, and P.T. Männistö Evolutionary relationships of the prolyl oligopeptidase family enzymes Eur. J. Biochem. 271 2004 2705 2715 (Pubitemid 38869971)
77. T. Vihavainen, T.R. Relander, R. Leiviska, M. Airavaara, R.K. Tuominen, L. Ahtee, and T.P. Piepponen Chronic nicotine modifies the effects of morphine on extracellular striatal dopamine and ventral tegmental GABA J. Neurochem. 107 2008 844 854
78. I.G. Vlasova, and A.L. Dolgopol'skii Substance P as a neuromodulator of cerebellar cholinergic systems Bull. Exp. Biol. Med. 130 2000 1035 1037 (Pubitemid 32396489)
79. R.S. Williams, M. Eames, W.J. Ryves, J. Viggars, and A.J. Harwood Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate EMBO J. 18 1999 2734 2745 (Pubitemid 29233946)